Category: NuvasiveSyndicate content

NuVasive launches spine surgery monitoring platform

June 23, 2014 by Brad Perriello

NuVasive launches the latest version of its NVM5 monitoring platform for spinal surgeries.

NuVasive launches spine surgery monitoring platform

NuVasive Inc. (NSDQ:NUVA) said today that it's launching the next generation of its NVM5 patient monitoring platform for spine surgeries.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DOJ probes St. Jude | Medtech legal news for the week of May 12, 2014

May 12, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Justice Dept. probes St. Jude for potential False Claims, kickbacks violations; More secret human studies uncovered in Myxo ring inquiry; Medtech manufacturer fleeced Stryker, says former exec; FDA morcellator warning spurs lawsuit against J&J; NuVasive claims win in patent spat with Cadwell Labs

Justice Dept. probes St. Jude for potential False Claims, kickbacks violations

May 6, 2014 by Arezu Sarvestani

NuVasive claims win in patent spat with Cadwell Labs

May 6, 2014 by Brad Perriello

NuVasive says it's settled a patent infringement lawsuit over neuromonitoring technology with Cadwell Laboratories, which agreed to exit the lateral spine surgery market and might be on the hook for royalties.

NuVasive settles patent spat with Cadwell Labs

NuVasive Inc. (NSDQ:NUVA) said today that Cadwell Laboratories agreed to settle a patent spat over neuromonitoring technology by exiting the lateral spine market and potentially paying 5% royalties to NuVasive for future products.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Legal loss pushes NuVasive to Q1 red

April 30, 2014 by Brad Perriello

A $30 million jury verdict in the trademark infringement battle with NeuroVision pushes NuVasive to a 1st-quarter loss.

Legal loss pushes NuVasive to Q1 red

NuVasive Inc. (NSDQ:NUVA) swung to a 1st-quarter loss after a jury ruled against it in a trademark infringement battle with NeuroVision, prompting the medical device company to lower its 2014 earnings outlook and investors to pare more than 2% from its share price.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive loses 2nd, $30M trademark trial against NeuroVision

April 4, 2014 by Brad Perriello

NuVasive pledges to appeal a $30 million loss in a trademark infringement lawsuit leveled against it by NeuroVision Medical Products, the 2nd time a court found against NuVasive.

NuVasive loses 2nd, $30M trademark trial against NeuroVision

UPDATED April 7, 2014, with comment from NeuroVision

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp